These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 21660879)

  • 1. Quetiapine dependence and withdrawal: a case report.
    Yargic I; Caferov C
    Subst Abus; 2011 Jul; 32(3):168-9. PubMed ID: 21660879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Misuse and abuse of quetiapine].
    Piróg-Balcerzak A; Habrat B; Mierzejewski P
    Psychiatr Pol; 2015; 49(1):81-93. PubMed ID: 25844412
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Quetiapine in substance use disorders, abuse and dependence possibility: a review].
    Erdoğan S
    Turk Psikiyatri Derg; 2010; 21(2):167-75. PubMed ID: 20514567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additional evidence of the abuse potential of quetiapine.
    Reeves RR; Brister JC
    South Med J; 2007 Aug; 100(8):834-6. PubMed ID: 17713313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Quetiapine and the potential for abuse].
    Aa E; Helland A; Spigset O
    Tidsskr Nor Laegeforen; 2012 Aug; 132(14):1619-20. PubMed ID: 22875127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case report of quetiapine withdrawal syndrome in a geriatric patient.
    Kohen I; Kremen N
    World J Biol Psychiatry; 2009; 10(4 Pt 3):985-6. PubMed ID: 17965985
    [No Abstract]   [Full Text] [Related]  

  • 7. Acute quetiapine dose-dependently exacerbates anhedonia induced by withdrawal from escalating doses of d-amphetamine.
    Zhornitsky S; Potvin S; Stip E; Rompré PP
    Eur Neuropsychopharmacol; 2010 Oct; 20(10):695-703. PubMed ID: 20605419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pregabalin Dependence: A Case Report].
    Aldemir E; Altıntoprak AE; Coşkunol H
    Turk Psikiyatri Derg; 2015; 26(3):217-20. PubMed ID: 26364177
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential benefits of quetiapine in the treatment of substance dependence disorders.
    Sattar SP; Bhatia SC; Petty F
    J Psychiatry Neurosci; 2004 Nov; 29(6):452-7. PubMed ID: 15644986
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does quetiapine have mood altering properties?
    Mishra A; Moore PB; Hobbs R
    J Psychopharmacol; 2004 Jun; 18(2):281-4. PubMed ID: 15260919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quetiapine: treatment for substance abuse and drug of abuse.
    Hanley MJ; Kenna GA
    Am J Health Syst Pharm; 2008 Apr; 65(7):611-8. PubMed ID: 18359967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Addictive potential of quetiapine.
    Murphy D; Bailey K; Stone M; Wirshing WC
    Am J Psychiatry; 2008 Jul; 165(7):918. PubMed ID: 18593794
    [No Abstract]   [Full Text] [Related]  

  • 13. [Symptoms after withdrawal of quetiapine].
    Lakartidningen; 2012 Sep 26-Oct 9; 109(39-40):1770. PubMed ID: 23097888
    [No Abstract]   [Full Text] [Related]  

  • 14. Reversible hyperkinetic movement disorder associated with quetiapine withdrawal.
    Ahmad MT; Prakash KM
    Mov Disord; 2010 Jul; 25(9):1308-9. PubMed ID: 20310037
    [No Abstract]   [Full Text] [Related]  

  • 15. Intravenous quetiapine-cocaine use ("Q-ball").
    Waters BM; Joshi KG
    Am J Psychiatry; 2007 Jan; 164(1):173-4. PubMed ID: 17202567
    [No Abstract]   [Full Text] [Related]  

  • 16. Quetiapine discontinuation syndrome.
    Kim DR; Staab JP
    Am J Psychiatry; 2005 May; 162(5):1020. PubMed ID: 15863814
    [No Abstract]   [Full Text] [Related]  

  • 17. Dependence on quetiapine in combination with zolpidem and clonazepam in bipolar depression.
    Chen CY; Shiah IS; Lee WK; Kuo SC; Huang CC; Wang TY
    Psychiatry Clin Neurosci; 2009 Jun; 63(3):427-8. PubMed ID: 19566779
    [No Abstract]   [Full Text] [Related]  

  • 18. Soluble interleukin-2 receptor levels correlated with positive symptoms during quetiapine treatment in schizophrenia-spectrum disorders.
    Igue R; Potvin S; Bah R; Stip E; Bouchard RH; Lipp O; Gendron A; Kouassi E
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1695-8. PubMed ID: 21627977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term adjunctive quetiapine may reduce substance use--a preliminary retrospective study.
    Sattar SP; Schultz SK; Arndt S; Soundy T; Petty F
    S D Med; 2007 Nov; 60(11):437, 439-41, 443 passim. PubMed ID: 18196687
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversible withdrawal dyskinesia associated with quetiapine.
    Michaelides C; Thakore-James M; Durso R
    Mov Disord; 2005 Jun; 20(6):769-70. PubMed ID: 15747370
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.